-
In this issue: Medication poisonings in children; rosuvastatin vs atorvastatin for atherosclerosis; saw palmetto for prostate symptoms; using atypical antipsychotics for off-label indications in adults; and FDA actions.
-
In a commentary on preterm birth (PTB) in the april issue of OB/GYN Clinical Alert, I mentioned that data are on the horizon that would support the use of vaginal progesterone to reduce the risk of PTB in patients with short cervices. Well, the study has now been published, and the results may change how PTB is approached.
-
A quick search on pubmed finds 122 manuscripts published in the first half of 2011 that reference the Women's Health Initiative (WHI) study in the title, abstract, or as a keyword.
-
-
Two recent studies have re-energized discussion regarding the safety of ultrasound a subject that pops up periodically and then disappears until a new study surfaces.
-
Due to the frequent identification of metastatic disease at diagnosis and its high associated mortality, ovarian cancer has been the persistent focus of many screening efforts.
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
In this double-blind protocol, normal-weight (body mass index [BMI] 19.0-24.9 kg/m2) and obese (BMI 30.0-39.9 kg/m2) women with regular periods and normal ovarian ultrasound took one of two types of oral contraceptives (OCPs): either 21-day monophasic pills with 20 mcg ethinyl estradiol/100 mcg levonorgestrel or 30 mcg ethinyl estradiol/150 mcg levonorgestrel.
-
This case-driven discussion of microscopic hematuria includes important guidelines, definitions, and reminders to aid the clinician in managing this common finding.
-
